Total Funding
N/A
Employee Range
1-10
Lento Bio, established in 2022 through a partnership with Ichor Life Sciences and Clarkson University’s Shipley Center for Innovation, focuses on developing safe and effective treatments for chronic age-related diseases by utilizing small molecules to directly target and repair molecular damage.
Lento Bio data powered by:
Share
Lento Bio data powered by:
Lento BioOverall Ranking
Regional Rank
Share
Loading...
In Western Europe
Top null%out of startups
Lento BioIndustry Rankings in
Ecommerce & Retail
City Rank
Share
3rd
In Potsdam
Top 100%out of 3 startups
National Rank
Share
531st
In Germany
Top 88%out of 608 startups
Regional Rank
Share
4,319th
In Western Europe
Top 87%out of 4980 startups
Lento BioSubindustry Rankings in
RetailCity Rank
Share
1st
In Potsdam
Top 100%out of 1 startups
National Rank
Share
12th
In Germany
Top 75%out of 16 startups
Regional Rank
Share
235th
In Western Europe
Top 82%out of 287 startups
rankings by:
Lento BioSB Rank Evolution
Not enough data points to display the chart.
Lento BiostartupComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro